Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial.
Silvain J, Lattuca B, Beygui F, Rangé G, Motovska Z, Dillinger JG, Boueri Z, Brunel P, Lhermusier T, Pouillot C, Larrieu-Ardilouze E, Boccara F, Labeque JN, Guedeney P, El Kasty M, Laredo M, Dumaine R, Ducrocq G, Collet JP, Cayla G, Blanchart K, Kala P, Vicaut E, Montalescot G; ALPHEUS investigators. Silvain J, et al. Among authors: beygui f. Lancet. 2020 Nov 28;396(10264):1737-1744. doi: 10.1016/S0140-6736(20)32236-4. Epub 2020 Nov 14. Lancet. 2020. PMID: 33202219 Free article. Clinical Trial.
Comparison of activated clotting times to heparin management test for adequacy of heparin anticoagulation in percutaneous transluminal coronary angioplasty.
Helft G, Choktron S, Beygui F, Le Feuvre C, Elalamy I, Metzger JP, Vacheron A, Samama MM. Helft G, et al. Among authors: beygui f. Cathet Cardiovasc Diagn. 1998 Nov;45(3):329-31. doi: 10.1002/(sici)1097-0304(199811)45:3<329::aid-ccd26>3.0.co;2-q. Cathet Cardiovasc Diagn. 1998. PMID: 9829899 Clinical Trial.
A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. STENTIM-2 Investigators.
Maillard L, Hamon M, Khalife K, Steg PG, Beygui F, Guermonprez JL, Spaulding CM, Boulenc JM, Lipiecki J, Lafont A, Brunel P, Grollier G, Koning R, Coste P, Favereau X, Lancelin B, Van Belle E, Serruys P, Monassier JP, Raynaud P. Maillard L, et al. Among authors: beygui f. J Am Coll Cardiol. 2000 Jun;35(7):1729-36. doi: 10.1016/s0735-1097(00)00612-4. J Am Coll Cardiol. 2000. PMID: 10841218 Free article. Clinical Trial.
The French Randomized Optimal Stenting Trial: a prospective evaluation of provisional stenting guided by coronary velocity reserve and quantitative coronary angiography. F.R.O.S.T. Study Group.
Lafont A, Dubois-Randé JL, Steg PG, Dupouy P, Carrié D, Coste P, Furber A, Beygui F, Feldman LJ, Rahal S, Tron C, Hamon M, Grollier G, Commeau P, Richard P, Colin P, Bauters C, Karrillon G, Ledru F, Citron B, Marié FN, Kern M. Lafont A, et al. Among authors: beygui f. J Am Coll Cardiol. 2000 Aug;36(2):404-9. doi: 10.1016/s0735-1097(00)00747-6. J Am Coll Cardiol. 2000. PMID: 10933349 Free article. Clinical Trial.
[Coronary angioplasty in hemodialysis patients].
Tabet S, Le Feuvre C, Dambrin G, Helft G, Beygui F, Vacheron A, Metzger JP. Tabet S, et al. Among authors: beygui f. Arch Mal Coeur Vaiss. 2000 Jul;93(7):807-12. Arch Mal Coeur Vaiss. 2000. PMID: 10975031 French.
210 results